Annotation Detail

Information
Associated Genes
IRS1
Associated Variants
IRS1 MUTATION
IRS1 MUTATION
Associated Disease
prostate carcinoma
Source Database
DisGeNET
Description
Demonstration that IRS expression can be increased in response to a variety of stressors that may lead to resistance or reduced effect of the therapies indicate that NT157-mediated IRS1/2 downregulation is a novel therapeutic approach for management of advanced prostate cancer.
Pubmed
25267499
Section of the abstract supporting the evidence
ALL_TEXT_3/3
Number of the section of the abstract supporting the evidence
3
Number of the sentence supporting the evidence
9
Original source reporting the Gene Disease association
BeFree
DisGENET score for the Gene Disease association
0.00135720936040152
Drugs